This compound is a modified nucleoside derivative used as a pharmaceutical intermediate in the manufacturing of oligonucleotides. It features a dimethoxytrityl protecting group and a 2-methoxyethoxy modification on the ribose sugar, as indicated by its structure and stereochemistry.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
1-(Mesitylene-2-sulfonyl)-3-nitro-1,2,4-triazole
pharmaceutical intermediate
N4-Ac-C-(S)-GNA phosphoramidite
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]purin-6-yl]benzamide
pharmaceutical intermediate
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
pharmaceutical intermediate
N-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-((2-cyanoethoxy)(diisopropylamino)phosphino)-2'-O-(2-methoxyethyl)-5-methylcytidine
pharmaceutical intermediate
5'-O-DMT-2'-(2-methoxyethyl)uridine 3'-CE phosphoramidite
pharmaceutical intermediate
(R)-4-Boc-2-methylpiperazine
pharmaceutical intermediate
(S)-2,4,5-Trifluoro-N-(1,1,1-trifluoropropan-2-yl)benzamide
pharmaceutical intermediate
1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-(2-methoxyethoxy)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
WIPCVBQXKBWNRC-PBAMLIMUSA-N
CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O)OCCOC
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.